Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk

Affiliations

¹ Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden.
² deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
³ Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA.
⁴ Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK.
⁵ Hematology Clinic, Lund University Hospital, 221 85, Lund, Sweden.
⁶ Department of Internal Medicine V, University Hospital of Heidelberg, 69120, Heidelberg, Germany.
⁷ Hematology Research Unit, Department of Clinical Research, University of Southern Denmark and Department of Hematology, Odense University Hospital, Odense, Denmark.
⁸ Department of Haematology, Aarhus University Hospital, 8200, Aarhus N, Denmark.
⁹ Södra Älvsborgs Sjukhus Borås, Borås, Sweden.
¹⁰ Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Department of Hematology, and Biobank1, St Olavs hospital, Trondheim, Norway.
¹¹ Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
¹² Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
¹³ Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.
¹⁴ Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA. bjorn.nilsson@med.lu.se.

Published Erratum

Laura Duran-Lozano et al. Blood Cancer J. 2021.

. 2021 Nov 16;11(11):181.

doi: 10.1038/s41408-021-00575-4.

¹ Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden.
² deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
³ Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA.
⁴ Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK.
⁵ Hematology Clinic, Lund University Hospital, 221 85, Lund, Sweden.
⁶ Department of Internal Medicine V, University Hospital of Heidelberg, 69120, Heidelberg, Germany.
⁷ Hematology Research Unit, Department of Clinical Research, University of Southern Denmark and Department of Hematology, Odense University Hospital, Odense, Denmark.
⁸ Department of Haematology, Aarhus University Hospital, 8200, Aarhus N, Denmark.
⁹ Södra Älvsborgs Sjukhus Borås, Borås, Sweden.
¹⁰ Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Department of Hematology, and Biobank1, St Olavs hospital, Trondheim, Norway.
¹¹ Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
¹² Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
¹³ Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.
¹⁴ Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA. bjorn.nilsson@med.lu.se.

No abstract available

Erratum for

Germline variants at SOHLH2 influence multiple myeloma risk.
Duran-Lozano L, Thorleifsson G, Lopez de Lapuente Portilla A, Niroula A, Went M, Thodberg M, Pertesi M, Ajore R, Cafaro C, Olason PI, Stefansdottir L, Bragi Walters G, Halldorsson GH, Turesson I, Kaiser MF, Weinhold N, Abildgaard N, Andersen NF, Mellqvist UH, Waage A, Juul-Vangsted A, Thorsteinsdottir U, Hansson M, Houlston R, Rafnar T, Stefansson K, Nilsson B. Duran-Lozano L, et al. Blood Cancer J. 2021 Apr 19;11(4):76. doi: 10.1038/s41408-021-00468-6. Blood Cancer J. 2021. PMID: 33875642 Free PMC article.